Johnson & Johnson on Tuesday said worldwide sales in its medical device unit declined 0.2% in the third quarter to $6.6 billion, as a negative currency impact of 1.9% outweighed an operational increase of 1.7%.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,